Viking Therapeutics
VKTX
VKTX
168 hedge funds and large institutions have $360M invested in Viking Therapeutics in 2018 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 72 increasing their positions, 37 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
4.4% more ownership
Funds ownership: 61.39% → 65.79% (+4.4%)
52% less capital invested
Capital invested by funds: $753M → $360M (-$394M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
168
Holding in Top 10
1
Calls
$8.42M
Puts
$6.59M
Top Buyers
| 1 | +$11.2M | |
| 2 | +$7.4M | |
| 3 | +$7.09M | |
| 4 |
BlackRock
New York
|
+$5.73M |
| 5 |
State Street
Boston,
Massachusetts
|
+$5.42M |
Top Sellers
| 1 | -$16.6M | |
| 2 | -$15.5M | |
| 3 | -$8.71M | |
| 4 |
DM
Deerfield Management
New York
|
-$8.01M |
| 5 |
NC
Nexthera Capital
New York
|
-$5.71M |